Phase III trial of Toca-511/Toca-FC in recurrent high-grade glioma misses primary endpoint Sep. 13, 2019
Phase I results of nivolumab, ipilimumab and nintedanib combination in advanced NSCLC presented Sep. 13, 2019
Spinal SGK1 is involved in the development of morphine tolerance through NF-kB p65/NMDAR signaling Sep. 13, 2019
RSS